Ignite Creation Date:
2024-05-05 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00487851
Status:
WITHDRAWN
Last Update Posted:
2013-04-12
First Post:
2007-06-18
Brief Title:
Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-resectable Periampullary Cancer
Sponsor:
Karolinska Institutet
Organization:
Karolinska Institutet
Study Overview
Official Title:
Endoscopic Strategy Versus Surgical by Pass in Nonresectable Periampullary Cancer
Status:
WITHDRAWN
Status Verified Date:
2013-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Withdrawn
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Randomized study comparing endoscopic stent insertion strategy versus double-bypass surgery in non-resectable periampullary cancer
Detailed Description:
Experience shows that patients with advanced periampullary cancer suffer not only from jaundice but in 25 -30 of cases also duodenal stricture with nausea vomiting and nutritional difficulties Ten years ago the only palliative treatment for these patients was a bypass operation for bile flow and intestinal passage This operation was often associated with a high morbidity Developments in endoscopic treatments allow palliation with lower morbidity However stent treatment is not free of problems like stent dysfunction During the last ten years anesthesia and surgical techniques have developed which allow lower postoperative morbidity compared to earlier treatments A total of 70 patients were randomized to surgery with hepaticojejunostomy on Roux loop and gastrojejunostomy or endoscopic treatment with self-expanding metallic stent in the bile duct and so-called duodenal stent Based on the inclusion of 70 patients we expected a 20 difference in some of the primary variables with a power of 80
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None